Statement | 02 May 2016 Research and development MSF at WHO's Open-Ended Meeting on CEWG - Agenda Item 5 (k) 3 min
Statement | 02 May 2016 Intellectual property and trade MSF at WHO's Open-Ended Meeting on CEWG - Agenda Item 5 (e) 3 min
Statement | 02 May 2016 Antimicrobial resistance Research and development MSF at WHO's Open-Ended Meeting on CEWG - Agenda Item 5 (a-d) 3 min
Statement | 19 February 2016 Tuberculosis MSF statement on a donation of TB drugs from Otsuka Pharmaceuticals 3 min
Statement | 01 February 2016 138th WHO EB - Addressing the global shortages of medicines, and the safety and accessibility of chidren’s medication
Statement | 29 January 2016 Research and development 138th WHO EB - Agenda Item 10.3: Follow-up of the report of the CEWG on R&D
Statement | 28 January 2016 Antimicrobial resistance 138th WHO EB - Agenda Item 8.5: Global Action Plan on Antimicrobial Resistance
